Belinda Lovelace, PharmD, MS, MJ

Senior Director, Heath Economics and Outcomes Research
F2G, Inc.

Disclosure(s): F2G Inc.: Employee

Poster(s):

• (P-1931) Aspergillosis-Attributable Death in the United States: Analysis of Death Certificate Data
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1932) Co-Administration of Triazoles with Calcineurin or mTOR Inhibitors in Solid Organ Transplant Patients Hospitalized with Invasive Aspergillosis
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1933) Co-Administration of Triazoles with Chemotherapy and/or Immunosuppressants Known to Have Moderate-to-Severe Drug-Drug Interactions in Patients with Hematologic Malignancies Who Are Hospitalized for Invasive Aspergillosis
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET